Factors influencing the prediction of steady state concentrations of digoxin

Tsutomu Nakamura, Mikio Kakumoto, Kazuhiko Yamashita, Kohji Takara, Yusuke Tanigawara, Toshiyuki Sakaeda, Katsuhiko Okumura

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The prediction error in the Bayesian analysis program for digoxin was evaluated in Japanese patients, and factors influencing the accuracy were investigated. Serum concentrations of digoxin were monitored two times and were compared with the predicted values obtained by using the Bayesian analysis program. The prediction error at the first time was 43.1%. Although this estimation error was reasonably restored at the second time of monitoring, the prediction error remained at 26.6%. These data suggested that unknown factors not included in the program affected the serum concentration of digoxin. Retrospective research of the digoxin serum concentrations in the patients suggested the coadministration of the drugs, which were the P-glycoprotein modulators, as well as the unexpected alteration of the serum creatinine, were the important factors influencing the prediction of the drug serum concentrations. We next examined the inhibitory effect of quinidine, verapamil and spironolactone on the transcellular transport of digoxin by using human P-glycoprotein overexpressing LLC-GA5-COL150 cells. Quinidine, verapamil and spironolactone could inhibit the transcellular transport of digoxin by 50%. In addition, the reduction of the renal clearance by 50%, which could possibly be caused by this inhibition, led to the increase of 36% in the steady state through concentrations of digoxin in the physiological pharmacokinetic model. In conclusion, the prediction of long-term serum concentration-time profiles of digoxin, based on the Bayesian analysis, will be disturbed by the coadministration of the P-glycoprotein modulators and the unexpected alteration of the serum creatinine.

Original languageEnglish
Pages (from-to)403-408
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume24
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Digoxin
Bayes Theorem
Serum
P-Glycoprotein
Transcytosis
Spironolactone
Creatinine
Pharmaceutical Preparations
Pharmacokinetics
Kidney
Research

Keywords

  • Concurrent drug
  • Digoxin
  • P-glycoprotein
  • Predicted concentration
  • Serum creatinine level

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Nakamura, T., Kakumoto, M., Yamashita, K., Takara, K., Tanigawara, Y., Sakaeda, T., & Okumura, K. (2001). Factors influencing the prediction of steady state concentrations of digoxin. Biological and Pharmaceutical Bulletin, 24(4), 403-408. https://doi.org/10.1248/bpb.24.403

Factors influencing the prediction of steady state concentrations of digoxin. / Nakamura, Tsutomu; Kakumoto, Mikio; Yamashita, Kazuhiko; Takara, Kohji; Tanigawara, Yusuke; Sakaeda, Toshiyuki; Okumura, Katsuhiko.

In: Biological and Pharmaceutical Bulletin, Vol. 24, No. 4, 2001, p. 403-408.

Research output: Contribution to journalArticle

Nakamura, T, Kakumoto, M, Yamashita, K, Takara, K, Tanigawara, Y, Sakaeda, T & Okumura, K 2001, 'Factors influencing the prediction of steady state concentrations of digoxin', Biological and Pharmaceutical Bulletin, vol. 24, no. 4, pp. 403-408. https://doi.org/10.1248/bpb.24.403
Nakamura, Tsutomu ; Kakumoto, Mikio ; Yamashita, Kazuhiko ; Takara, Kohji ; Tanigawara, Yusuke ; Sakaeda, Toshiyuki ; Okumura, Katsuhiko. / Factors influencing the prediction of steady state concentrations of digoxin. In: Biological and Pharmaceutical Bulletin. 2001 ; Vol. 24, No. 4. pp. 403-408.
@article{338278ff843e44aa976fccc2e0e0002d,
title = "Factors influencing the prediction of steady state concentrations of digoxin",
abstract = "The prediction error in the Bayesian analysis program for digoxin was evaluated in Japanese patients, and factors influencing the accuracy were investigated. Serum concentrations of digoxin were monitored two times and were compared with the predicted values obtained by using the Bayesian analysis program. The prediction error at the first time was 43.1{\%}. Although this estimation error was reasonably restored at the second time of monitoring, the prediction error remained at 26.6{\%}. These data suggested that unknown factors not included in the program affected the serum concentration of digoxin. Retrospective research of the digoxin serum concentrations in the patients suggested the coadministration of the drugs, which were the P-glycoprotein modulators, as well as the unexpected alteration of the serum creatinine, were the important factors influencing the prediction of the drug serum concentrations. We next examined the inhibitory effect of quinidine, verapamil and spironolactone on the transcellular transport of digoxin by using human P-glycoprotein overexpressing LLC-GA5-COL150 cells. Quinidine, verapamil and spironolactone could inhibit the transcellular transport of digoxin by 50{\%}. In addition, the reduction of the renal clearance by 50{\%}, which could possibly be caused by this inhibition, led to the increase of 36{\%} in the steady state through concentrations of digoxin in the physiological pharmacokinetic model. In conclusion, the prediction of long-term serum concentration-time profiles of digoxin, based on the Bayesian analysis, will be disturbed by the coadministration of the P-glycoprotein modulators and the unexpected alteration of the serum creatinine.",
keywords = "Concurrent drug, Digoxin, P-glycoprotein, Predicted concentration, Serum creatinine level",
author = "Tsutomu Nakamura and Mikio Kakumoto and Kazuhiko Yamashita and Kohji Takara and Yusuke Tanigawara and Toshiyuki Sakaeda and Katsuhiko Okumura",
year = "2001",
doi = "10.1248/bpb.24.403",
language = "English",
volume = "24",
pages = "403--408",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Factors influencing the prediction of steady state concentrations of digoxin

AU - Nakamura, Tsutomu

AU - Kakumoto, Mikio

AU - Yamashita, Kazuhiko

AU - Takara, Kohji

AU - Tanigawara, Yusuke

AU - Sakaeda, Toshiyuki

AU - Okumura, Katsuhiko

PY - 2001

Y1 - 2001

N2 - The prediction error in the Bayesian analysis program for digoxin was evaluated in Japanese patients, and factors influencing the accuracy were investigated. Serum concentrations of digoxin were monitored two times and were compared with the predicted values obtained by using the Bayesian analysis program. The prediction error at the first time was 43.1%. Although this estimation error was reasonably restored at the second time of monitoring, the prediction error remained at 26.6%. These data suggested that unknown factors not included in the program affected the serum concentration of digoxin. Retrospective research of the digoxin serum concentrations in the patients suggested the coadministration of the drugs, which were the P-glycoprotein modulators, as well as the unexpected alteration of the serum creatinine, were the important factors influencing the prediction of the drug serum concentrations. We next examined the inhibitory effect of quinidine, verapamil and spironolactone on the transcellular transport of digoxin by using human P-glycoprotein overexpressing LLC-GA5-COL150 cells. Quinidine, verapamil and spironolactone could inhibit the transcellular transport of digoxin by 50%. In addition, the reduction of the renal clearance by 50%, which could possibly be caused by this inhibition, led to the increase of 36% in the steady state through concentrations of digoxin in the physiological pharmacokinetic model. In conclusion, the prediction of long-term serum concentration-time profiles of digoxin, based on the Bayesian analysis, will be disturbed by the coadministration of the P-glycoprotein modulators and the unexpected alteration of the serum creatinine.

AB - The prediction error in the Bayesian analysis program for digoxin was evaluated in Japanese patients, and factors influencing the accuracy were investigated. Serum concentrations of digoxin were monitored two times and were compared with the predicted values obtained by using the Bayesian analysis program. The prediction error at the first time was 43.1%. Although this estimation error was reasonably restored at the second time of monitoring, the prediction error remained at 26.6%. These data suggested that unknown factors not included in the program affected the serum concentration of digoxin. Retrospective research of the digoxin serum concentrations in the patients suggested the coadministration of the drugs, which were the P-glycoprotein modulators, as well as the unexpected alteration of the serum creatinine, were the important factors influencing the prediction of the drug serum concentrations. We next examined the inhibitory effect of quinidine, verapamil and spironolactone on the transcellular transport of digoxin by using human P-glycoprotein overexpressing LLC-GA5-COL150 cells. Quinidine, verapamil and spironolactone could inhibit the transcellular transport of digoxin by 50%. In addition, the reduction of the renal clearance by 50%, which could possibly be caused by this inhibition, led to the increase of 36% in the steady state through concentrations of digoxin in the physiological pharmacokinetic model. In conclusion, the prediction of long-term serum concentration-time profiles of digoxin, based on the Bayesian analysis, will be disturbed by the coadministration of the P-glycoprotein modulators and the unexpected alteration of the serum creatinine.

KW - Concurrent drug

KW - Digoxin

KW - P-glycoprotein

KW - Predicted concentration

KW - Serum creatinine level

UR - http://www.scopus.com/inward/record.url?scp=0035040420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035040420&partnerID=8YFLogxK

U2 - 10.1248/bpb.24.403

DO - 10.1248/bpb.24.403

M3 - Article

C2 - 11305603

AN - SCOPUS:0035040420

VL - 24

SP - 403

EP - 408

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 4

ER -